Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Immunosuppression in corneal transplantation].

S Scheer1, O Touzeau, V Borderie

  • 1Service d'Ophtlamologie V, Centre Hospitalier National d'Ophtalmologie des XV-XX, 28, rue de Charenton, 75012 Paris.

Journal Francais D'Ophtalmologie
|August 12, 2003
PubMed
Summary

Corneal graft rejection is common. While topical corticosteroids are standard, they have side effects. Cyclosporine offers targeted immunosuppression but has its own risks and is not for acute rejection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and safety of intraocular folding sutureless scleral fixating lens versus iris-claw intraocular lens implantation.

Journal francais d'ophtalmologie·2022
Same author

Epidemiological changes in cutaneous lymphomas: an analysis of 8593 patients from the French Cutaneous Lymphoma Registry.

The British journal of dermatology·2020
Same author

Boosting the sterile insect technique with pyriproxyfen increases tsetse flies Glossina palpalis gambiensis sterilization in controlled conditions.

Scientific reports·2020
Same author

Atypical severe diffuse lamellar keratitis presenting as concentric rings after femtosecond laser-assisted small-incision lenticule extraction (SMILE).

Journal francais d'ophtalmologie·2020
Same author

Sterile keratitis following standard corneal collagen crosslinking: A case series and literature review.

Journal francais d'ophtalmologie·2019
Same author

[In vivo confocal microscopy and optical coherence tomography in stromal corneal dystrophies].

Journal francais d'ophtalmologie·2019

Area of Science:

  • Ophthalmology
  • Immunology
  • Transplantation

Background:

  • Corneal graft rejection, driven by immune privilege loss, necessitates immunosuppression.
  • Topical corticosteroids are the current standard for preventing and treating corneal graft rejection.
  • Corticosteroids are non-specific and associated with significant side effects like glaucoma and infections.

Purpose of the Study:

  • To evaluate the efficacy and safety of various immunosuppressive therapies for corneal graft rejection.
  • To compare topical corticosteroids with cyclosporine and other emerging agents.
  • To identify optimal strategies for preventing corneal graft failure.

Main Methods:

  • Review of current literature on immunosuppressive agents used in corneal transplantation.

Related Experiment Videos

  • Analysis of clinical outcomes and side effect profiles of topical corticosteroids and cyclosporine.
  • Assessment of the potential of newer agents like mycophenolate mofetil and FK 506.

    • Main Results:

    • Topical corticosteroids are effective but cause side effects; they are the only treatment for acute rejection.
    • Oral cyclosporine prevents rejection in high-risk cases but carries systemic risks.
    • Topical cyclosporine can substitute for steroids in specific situations but causes epithelial defects and is not for acute rejection.

    Conclusions:

    • Current immunosuppressive strategies for corneal grafts have limitations and side effects.
    • Cyclosporine offers targeted action but is not a universal solution and has its own adverse effects.
    • Further research is needed for safer and more effective treatments to prevent corneal graft rejection.